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Infections due to Mycobacterium abscessus carry a poor prognosis since this rapidly
growing mycobacterium is intrinsically resistant to most antibiotics. Here, we evaluate
the in vitro activity of the new oxazolidinone tedizolid against a collection of 44M.
abscessus clinical isolates. The MICs and MICs of tedizolid (2 and 8μg/mL,
respectively) were 2- to 16-fold lower than those of linezolid. There was no difference
between the 3M. abscessus subspecies. Time-kill assays did not show any bactericidal
activity at 4- and 8-fold the MIC. Combination of tedizolid with clarithromycin was
synergistic against 1 out of 6 isolates, while indifferent interactions were observed for
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